PRODROMAL ALZHEIMER'S DISEASE
Clinical trials for PRODROMAL ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRODROMAL ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PRODROMAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Alzheimer's vaccine trial aims to slow memory loss
Disease control Not yet recruitingThis study is testing whether a vaccine called AADvac1 can slow the progression of Alzheimer's disease in its earliest stages. It will involve 375 adults aged 50-80 who have very early signs of the disease. The vaccine targets a protein called tau, and researchers will see if it …
Matched conditions: PRODROMAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope in fight against Alzheimer's: Dual-Attack drug trial launches
Disease control Not yet recruitingThis clinical trial aims to test whether new drugs that target tau protein in the brain can slow Alzheimer's disease progression, either alone or combined with existing amyloid-targeting treatments. It will enroll 750 adults aged 50-80 who have early signs of Alzheimer's but mini…
Matched conditions: PRODROMAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC